| | |
| Celiac diagnoses rose during 2000s: study Friday, Mar 29, 2013 12:41 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - The number of Americans diagnosed with celiac disease continued to rise over the past decade but leveled off in 2004, according to a new study. Researchers analyzed data on a small but representative sample of people living in Olmsted County, Minnesota, and found that between the years 2000 and 2010, the number of new cases of celiac disease increased from about 11 people per 100,000 to about 17 people per 100,000. "We're finding a lot more celiac disease," said Dr. ... Full Story | Top |
| FDA clears Johnson & Johnson type 2 diabetes drug Invokana Friday, Mar 29, 2013 12:13 PM PDT WASHINGTON (Reuters) - The U.S. Food and Drug Administration said on Friday it approved Johnson & Johnson's experimental type 2 diabetes drug Invokana to help patients control their blood sugar. (Reporting By Kim Dixon; editing by Christopher Wilson) Full Story | Top |
| Oklahoma warns 7,000 dental patients of HIV, hepatitis risk Friday, Mar 29, 2013 11:17 AM PDT By Steve Olafson OKLAHOMA CITY (Reuters) - Health officials are notifying some 7,000 people to warn they may have been exposed to HIV and other infectious diseases at an Oklahoma dental practice where improper sterilization procedures and rusty surgical tools were discovered, authorities said. The investigation was launched after a patient of Dr. Wayne Scott Harrington of Tulsa was diagnosed with hepatitis C and HIV, the virus that causes AIDS, according to a complaint filed against the oral surgeon. ... Full Story | Top |
| Biogen prices new MS drug at discount to key competitors Friday, Mar 29, 2013 11:06 AM PDT  WASHINGTON (Reuters) - Biogen Idec Inc said on Friday it will charge $54,900 a year for its multiple sclerosis drug, Tecfidera, which received U.S. approval on Wednesday. The company has priced the drug at a discount to key competitors such as Novartis AG's MS pill Gilenya, which costs roughly $60,000 a year, in a bid to maximize its market share. "We think this represents solid value to the MS community and demonstrates our commitment to patient access," said Kate Niazi-Sai, a Biogen spokeswoman. ... Full Story | Top |
| Sicily revokes permission for U.S. military satellite station Friday, Mar 29, 2013 11:04 AM PDT PALERMO, Italy (Reuters) - The Sicilian regional government in Italy has revoked permission for the United States to build a military satellite station on the island, its governor said on Friday, after protests by residents who said it could pose a health risk. The planned ground station was part of the Mobile User Objective System (MUOS), an ultra high-frequency satellite network aimed at significantly boosting communications capacity for the U.S. military and its allies. ... Full Story | Top |
| Robotic surgery tied to temporary nerve injuries Friday, Mar 29, 2013 11:03 AM PDT By Genevra Pittman NEW YORK (Reuters Health) - One in 15 people undergoing robot-assisted prostate, kidney or bladder surgery develops a nerve injury related to pressure from positioning on the operating table, a new study suggests. Patients on the table getting those types of robotic surgery need to be tilted steeply - with their head by the floor and their feet in the air - to give the surgeon better traction, researchers explained. "When somebody is in that position, there's a chance they could slide down - it's like a big ramp," said lead author Dr. ... Full Story | Top |
| Chinese herbs may reduce hot flashes Friday, Mar 29, 2013 10:33 AM PDT By Kerry Grens NEW YORK (Reuters Health) - Women taking a Chinese herbal formula experienced less than half the number of menopausal hot flashes they had before the treatment, according to a new study from Hong Kong. Among women taking an herbal mix called Er-xian decoction (EXD), the frequency of daily hot flashes dropped by 62 percent, compared to a 52-percent drop seen among women taking a placebo. "It's a modest effect, but not a zero effect," said Katherine Newton, a researcher who has studied herbal menopause therapies at the Group Health Research Institute in Seattle. ... Full Story | Top |
| South Africa says Mandela makes progress, in good spirits Friday, Mar 29, 2013 05:42 AM PDT  By Shafiek Tassiem SOWETO, South Africa (Reuters) - South African former President Nelson Mandela is in good spirits and making progress, doctors said on Friday, after the 94-year-old anti-apartheid hero was taken to hospital for the third time in four months for a lung infection. The medical report was a relief to South Africans who had been anxiously praying and waiting for an update on the health of the Nobel Peace Prize laureate, hospitalised before midnight on Wednesday. Global leaders sent their best wishes. ... Full Story | Top |
| Sony, Olympus delay medical venture as regulatory approval on hold Thursday, Mar 28, 2013 11:55 PM PDT  TOKYO (Reuters) - Japan's Sony Corp and Olympus Corp have again delayed the start of a joint venture to develop medical equipment because they have yet to gain approval from some regulators. "The examination by the relevant authority is taking longer than expected," the two companies said in a statement. They did not set a new date for operations to start. Plans by the Japanese companies to establish a joint venture to design and build medical devices have struggled to win approval in China, according to a source at one of the corporations familiar with the matter. ... Full Story | Top |
| Pfizer fails to end lawsuit over Bextra, Celebrex safety Thursday, Mar 28, 2013 04:57 PM PDT  By Jonathan Stempel (Reuters) - Pfizer Inc has failed to persuade a federal judge to dismiss a shareholder lawsuit accusing the company of fraudulently misrepresenting the safety of its Celebrex and Bextra pain-relieving drugs. While dismissing some of the claims, U.S. District Judge Laura Taylor Swain in Manhattan said a reasonable jury could find that Pfizer and several top executives intended to mislead shareholders about the drugs' cardiovascular risks. ... Full Story | Top |
| Prescription drugs cost least at Costco and most at CVS: study Thursday, Mar 28, 2013 03:44 PM PDT  By Debra Sherman (Reuters) - Some of the most popular prescription drugs that recently became available in generic form are sold at the lowest prices at Costco and at the highest prices at CVS Caremark, according to an analysis by Consumer Reports. Failing to comparison shop for drugs - such as generic Lipitor to lower cholesterol or generic Plavix to thin the blood - could result in overpaying by $100 a month or even more, depending on the drug, the report said. The article will be available in the May issue of Consumer Reports. ... Full Story | Top |
| Animal rights groups sue FDA over egg labeling concerns Thursday, Mar 28, 2013 03:32 PM PDT (Reuters) - Animal rights advocates on Thursday sued U.S. regulators to correct what they say is misleading labeling on cartons of eggs that come from caged hens. The lawsuit comes more than seven years after animal rights groups started petitioning the federal government to take action, with no success. The suit, filed in U.S. ... Full Story | Top |
| Obese airline passengers should pay extra, economist says Thursday, Mar 28, 2013 03:14 PM PDT  (Reuters) - Airlines should charge obese passengers more, a Norwegian economist has suggested, arguing that "pay as you weigh" pricing would bring health, financial and environmental dividends. Bharat Bhatta, an associate professor at Sogn og Fjordane University College, said that airlines should follow other transport sectors and charge by space and weight. "To the degree that passengers lose weight and therefore reduce fares, the savings that result are net benefits to the passengers," Bhatta wrote this week in the Journal of Revenue and Pricing Management. ... Full Story | Top |
| South Africa's Mandela "responding positively" to treatment Thursday, Mar 28, 2013 01:52 PM PDT  By Ed Stoddard JOHANNESBURG (Reuters) - Former South African President Nelson Mandela is "responding positively" to treatment for a recurring lung infection after being admitted to hospital overnight, the government said on Thursday. "He remains under treatment and observation in hospital," it added in a statement, without giving further details about the health of the 94-year-old anti-apartheid leader. ... Full Story | Top |
| Elite women's college rejects transgender student, prompts outcry Thursday, Mar 28, 2013 01:51 PM PDT By Zach Howard NORTHAMPTON, Massachusetts (Reuters) - A transgender high school student has had her application to a prestigious all-women's college denied because she is tagged as legally male on government documents, prompting a vocal online and social media campaign on her behalf. Calliope Wong, 17, a Connecticut senior who was born a male but has identified as female since adolescence, says Smith College in Northampton, Massachusetts, twice opted not to read her application and returned it in the mail. ... Full Story | Top |
|
No comments:
Post a Comment